The influence of PM2.5 exposure on SARS-CoV-2 infection via modulating the expression of angiotensin converting enzyme II.

Publication date: Mar 05, 2025

Particulate matter 2. 5 (PM2. 5) pollution and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic are the greatest environmental health issues worldwide. Several statistics revealed the significant positive correlation between the morbidity of coronavirus disease-19 (COVID-19) and the levels of air pollution. Nevertheless, there is no direct experimental evidence to indicate the effect of PM2. 5 exposure on SARS-CoV-2 infection. The objective of this study was to evaluate whether the infection of SARS-CoV-2 affected by PM2. 5 through angiotensin-converting enzyme II (ACE2) expression enhances and investigate the function of ACE2 in lung injury induced by PM2. 5. An animal model of PM2. 5-induced lung injury was established using wild-type (WT, C57BL/6), human ACE2 transgenic (K18-hACE2 TG), and murine ACE2 gene knockout (mACE2 KO) mice. The results indicate that PM2. 5 exposure facilitates SARS-CoV-2 infection through inducing ACE2 expression in vitro (10 μg/mL) and in vivo (6. 25 mg/kg/day in 50 μL saline). The levels of ACE, inflammatory cytokines, and mitogen-activated protein kinase (MAPK) proteins in WT, K18-hACE TG and mACE2 KO mice were significantly increased after PM2. 5 instillation. The severest PM2. 5-induced lung damage was observed in mACE2 KO mice. In summary, ACE2 plays a double-edged sword role in lung injury, PM2. 5 exposure contributed to SARS-CoV-2 infection through inducing ACE2 expression, but ACE2 also protected pulmonary inflammation from PM2. 5 challenge.

Concepts Keywords
Coronavirus ACE2 protein, human
Environmental Ace2 protein, mouse
Greatest Air Pollutants
Mice Air Pollutants
Mitogen Air pollution
Angiotensin-Converting Enzyme 2
Angiotensin-Converting Enzyme 2
Animals
COVID-19
Cytokines
Cytokines
Humans
Inflammation
Lung
Lung Injury
Male
Mice
Mice, Knockout
Mice, Transgenic
Particulate Matter
Particulate Matter
Particulate matter 2.5
SARS-CoV-2

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH morbidity
drug DRUGBANK Medical air
disease MESH infection
disease MESH lung injury
disease IDO role
disease MESH pulmonary inflammation
disease MESH Inflammation

Original Article

(Visited 1 times, 1 visits today)